Cigna Group financial data

Symbol
CI on NYSE
Location
Bloomfield, CT
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 30 Oct 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 81% % -2%
Quick Ratio 10% % 7.4%
Debt-to-equity 277% % 5.7%
Operating Margin 3.4% % -16%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 267,125,816 shares -4%
Common Stock, Shares, Outstanding 273,789,000 shares -6.4%
Entity Public Float $92,100,000,000 USD 11%
Common Stock, Value, Issued $4,000,000 USD 0%
Weighted Average Number of Shares Outstanding, Diluted 267,530,000 shares -4.9%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $268,077,000,000 USD 15%
Operating Income (Loss) $9,028,000,000 USD -3%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $7,973,000,000 USD 131%
Income Tax Expense (Benefit) $1,423,000,000 USD 1337%
Earnings Per Share, Basic 22 USD/shares 112%
Earnings Per Share, Diluted 22 USD/shares 113%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $6,025,000,000 USD 2.3%
Inventory, Net $5,632,000,000 USD 11%
Other Assets, Current $2,486,000,000 USD -6.8%
Assets, Current $46,735,000,000 USD -5.1%
Other Long-term Investments $4,884,000,000 USD
Intangible Assets, Net (Excluding Goodwill) $28,975,000,000 USD -2.7%
Goodwill $44,924,000,000 USD 1.2%
Other Assets, Noncurrent $3,389,000,000 USD 6.6%
Assets $157,919,000,000 USD 0.18%
Accounts Payable, Current $9,346,000,000 USD 9.8%
Liabilities, Current $56,453,000,000 USD -1.1%
Long-term Debt and Lease Obligation $30,947,000,000 USD 2.4%
Deferred Income Tax Liabilities, Net $6,997,000,000 USD 3%
Other Liabilities, Noncurrent $3,873,000,000 USD 28%
Liabilities $115,905,000,000 USD 0.49%
Accumulated Other Comprehensive Income (Loss), Net of Tax $2,799,000,000 USD -29%
Retained Earnings (Accumulated Deficit) $47,028,000,000 USD 11%
Stockholders' Equity Attributable to Parent $41,805,000,000 USD -0.69%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $42,014,000,000 USD -0.67%
Liabilities and Equity $157,919,000,000 USD 0.18%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $1,920,000,000 USD -60%
Net Cash Provided by (Used in) Financing Activities $3,681,000,000 USD -46%
Net Cash Provided by (Used in) Investing Activities $1,197,000,000 USD
Common Stock, Shares Authorized 600,000,000 shares 0%
Common Stock, Shares, Issued 404,000,000 shares 0.5%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $555,000,000 USD -131%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $6,071,000,000 USD 2.3%
Interest Paid, Excluding Capitalized Interest, Operating Activities $379,000,000 USD 13%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $5,511,000,000 USD 84%
Preferred Stock, Shares Authorized 25,000,000 shares 0%
Unrecognized Tax Benefits $1,477,000,000 USD 5.6%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets $1,704,000,000 USD -1.5%
Depreciation, Depletion and Amortization $2,699,000,000 USD 7.2%
Preferred Stock, Par or Stated Value Per Share 1 USD/shares 0%